Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review)-Reference-Cited by-同舟云学术

Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review)

Published:2024-08-05 Issue:4 Volume:54 Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Sidiropoulou Polytimi¹,Katsarou Martha²,Sifaki Maria²,Papasavva Maria³,Drakoulis Nikolaos²

Affiliation:

1. 1st Department of Dermatology‑Venereology, School of Medicine, National and Kapodistrian University of Athens, ‘A. Sygros’ Hospital for Skin and Venereal Diseases, 16121 Athens, Greece

2. Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece

3. Department of Pharmacy, School of Health Sciences, Frederick University, 1036 Nicosia, Cyprus

Publisher

Spandidos Publications

Reference147 articles.

1. Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases;Rodriguez-Cerdeira;Mediators Inflamm,2012

2. Therapeutic potential of macrolide immunosuppressants in dermatology;Marsland;Expert Opin Investig Drugs,2004

3. The golden ages of inflammatory skin diseases: Skyrocketing developments in the therapy of psoriasis and atopic dermatitis;Kemény;Acad Dermatol Venereol,2021

4. Topical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysis;Leducq;J Am Acad Dermatol,2019

5. Calcineurin inhibitors and sirolimus: Mechanisms of action and applications in dermatology;Reynolds;Clin Exp Dermatol,2002